Oracle acquires Relsys, Californian editor of software of the risks management for the attention of the pharmaceutical industry and biotechnologies.
The integration of the Relsys solutions has to allow the American publisher, the competitor of the German group SAP, to supply a continuation of pharmacovigilance applications (risk supervision, from the clinical trials to the use of medicines in real situation) within the framework of the Health Sciences Global Business unit. With the Relsys integration, Oracle is ideally positioned to help their customers to improve the safety of medicines by supplying a solution which groups together risk management tools and advanced analysis.
- European Medicines Agency publishes tenth weekly pandemic pharmacovigilance report, Press Office
- Revision of Appendix II "Translation of the MedDRA" terminology for frequencies and system organ classes to be used in SPC Section 4.8 "Undesirable effects": minor changes in the Greek version, Human Medicines, Application Procedures- QRD- Product Information Templates.
- European Medicines Agency publishes ninth weekly pandemic pharmacovigilance report, Press Office
Bulletin of the French health authority dated from January 08, 2010:
Health Authority News:
Health Authority Project 2009 - 2011 will be about these following points:
PUT THE QUALITY IN THE HEART OF the PRACTICES AND THE INDIVIDUAL BEHAVIORPUT THE QUALITY IN THE HEART OF the COLLECTIVE CHOICES STRENGTHEN THE PERFORMANCE, THE TRANSPARENCY AND THE EXPERTISE OF THE INSTITUTION
News of 2009
|
|